Paracelsus Medizinische Privatuniversität (PMU)

Research & Innovation
Publications

Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer (vol 16, pg 867, 2005)

#2006
#ANTI-CANCER DRUGS

PMU Authors
Roland Reitsamer, Florentia Peintinger, Wolfgang Hitzl

All Authors
Roland Reitsamer, Florentia Peintinger, E. Prokop, Wolfgang Hitzl

Journal association
ANTI-CANCER DRUGS

Abstract

We are sorry. The full text is not available.